WASHINGTON, DC - The Subcommittee on Oversight and Investigations, chaired by Rep. Gregg Harper (R-MS) today announced the details for its hearing with the leadership of national and regional drug distributors in regards to the committee’s bipartisan investigation into opioid distribution practices, particularly alleged pill dumping in West Virginia.
The hearing will be held on Tuesday, May 8, 2018, at 10 a.m. in room 2123 of the Rayburn House Office Building. The hearing is entitled, “Combating the Opioid Epidemic: Examining Concerns About Distribution and Diversion." The hearing falls on the one-year anniversary of the committee’s initial requests for information regarding distribution practices in West Virginia.
#SubOversight has confirmed the following witnesses will testify:
* Mr. John Hammergren, Chairman, President and CEO, McKesson Corporation;
* Mr. George Barrett, Executive Chairman of the Board, Cardinal Health Inc.;
* Mr. Steven Collis, Chairman, President and CEO, AmerisourceBergen Corporation;
* Dr. Joseph Mastandrea, Chairman of the Board, Miami-Luken, Inc.; and
* Mr. J. Christopher Smith, former President and CEO, H.D. Smith Wholesale Drug Company.
The hearing was first announced on April 12, 2018.as they are posted.
